Back
Kymera Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
KYMR
Kymera Therapeutics
Last Price:
44.98
Seasonality Move:
21.35%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.29 | Buy |
| 20-day SMA: | 46.96 | Sell |
| 50-day SMA: | 46.95 | Sell |
| 200-day SMA: | 40.89 | Buy |
| 8-day EMA: | 44.79 | Buy |
| 20-day EMA: | 46.07 | Sell |
| 50-day EMA: | 46.21 | Sell |
| 200-day EMA: | 40.46 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 45.79 | Sell |
| Chaikin Money Flow: | 155529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.56 - 49.8) | Sell |
| Bollinger Bands (100): | (41.29 - 49.23) | Sell |
Kymera Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 44.98 while KYMR 8-day simple moving average is 44.29, which is a Buy signal.
- The stock price of KYMR is 44.98 while Kymera Therapeutics 20-day SMA is 46.96, which makes it a Sell.
- Kymera Therapeutics 50-day simple moving average is 46.95 while KYMR share price is 44.98, making it a Sell technically.
- KYMR stock price is 44.98 and Kymera Therapeutics 200-day simple moving average is 40.89, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $44.98. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.91B
Price in USD:
44.98
Share Volume:
559.06K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
18.89
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 44.98 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 44.98 while KYMR 8-day exponential moving average is 44.79, which is a Buy signal.
- The stock price of KYMR is 44.98 while Kymera Therapeutics 20-day EMA is 46.07, which makes it a Sell.
- Kymera Therapeutics 50-day exponential moving average is 46.21 while KYMR share price is 44.98, making it a Sell technically.
- KYMR stock price is 44.98 and Kymera Therapeutics 200-day simple moving average is 40.46, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.51 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is -0.89, suggesting Kymera Therapeutics is a Sell
- Kymera Therapeutics Relative Strength Index (RSI) is 45.79, which suggest Kymera Therapeutics is oversold
- The Bollinger Bands (25) for Kymera Therapeutics is (44.56 - 49.8), which suggest Kymera Therapeutics is a Sell
- The Bollinger Bands (100) for Kymera Therapeutics is (41.29 - 49.23), which suggest Kymera Therapeutics is a Sell
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.